House leadership may bring the crackdown on Chinese biotech companies up for a floor vote later this month, sources tell Peter. Why it matters: The prospect underscores the momentum behind the bipartisan Biosecure Act, which could shake up the life sciences sector and require biotech firms to rework their relationships around targeted companies...